Networking Meeting Summary

June 12 FOCM | GLSA Online Networking Event Recap

2024 Mid-year Highlights: A Successful Gathering

On June 12, the Global Life Sciences Alliance (GLSA) hosted an engaging online networking event focusing on the 2024 mid-year highlights. The event saw a robust turnout with 35 participants, blending familiar faces with new members, fostering a vibrant and dynamic discussion.

Opening Remarks and Industry Updates

Chris Matheus kicked off the event with a warm welcome, introducing new members and setting the stage with industry updates, news, and conference reviews. Participants shared their travel plans, locations, and upcoming trips, adding a personal touch to the professional gathering.

Networking and Collaborative Initiatives

The meeting adopted an open house format, encouraging participants to share their LinkedIn profiles for seamless networking. Chris also promoted the Women of Life Sciences virtual event and called for volunteers to judge the best giveaways at the upcoming DIA, led by Sheila Mahoney-Jewels (smj@lifescihub.com).

GLSA’s Mission and Conference Insights

The GLSA reiterated its mission to provide solutions for clinical trial issues. Michael Young, Brian Langin, Cameron Robinson, and Denise McNerney shared insights from the BIO conference, which boasted over 19,000 attendees. Michael also reviewed the heavily attended ASCO conference, noting a significant presence of first-time exhibitors and attendees.

Business Update and Market Analysis

Chris Matheus presented a detailed analysis of the business performance in the first half of the year. He discussed the initial surge in activity, followed by a slowdown in decision-making and funding optimism. Chris also covered the recent Federal Open Market Committee meeting, touching on global uncertainties and their potential impact on market trends, including the upcoming US presidential election and geopolitical tensions.

Advances in Drug Approvals and Precision Medicine

Recent advancements in drug approvals for NASH/fatty liver and Alzheimer’s were highlighted, with Michael Young discussing precision medicine’s role in oncology drug development. Notable Labs’ blood test and Keliomics’ ex vivo tumor models, presented at ASCO, were showcased as revolutionary innovations that could transform early-stage development.

AI and ML Applications in Clinical Trials

Chris Matheus explored the applications of AI and machine learning in clinical trials. He highlighted the potential for large-scale simulations and AI tools to predict patient enrollment and rank doctors. Despite enthusiasm, participants expressed skepticism regarding the current state of these technologies, particularly in patient enrollment and regulatory validation.

Challenges in Patient Enrollment and Hiring Trends

The discussion also addressed the challenges in patient enrollment post-COVID and hiring trends. Michael Young and Chris Matheus were optimistic about the resurgence of in-person conferences, citing high attendance at recent events. Lisamarie O’Brien highlighted the difficulties in hiring, emphasizing the need for smarter recruitment strategies and the role of AI in applicant tracking systems.

AI in Language Translation and Clinical Studies

Duncan Shaw highlighted the challenges of using AI for language translation and clinical studies, stressing the need for exactness and precision. The group echoed these sentiments, agreeing on the importance of patience and caution in evaluating AI’s potential in these areas.

AI and Budget Building Challenges

Mike O’Gorman shared concerns about AI’s capabilities in budget building, while Ira Snyder emphasized the limitations in obtaining precise budgetary details due to data quality issues.

Site Negotiations and Challenges

The slow progress in securing site contracts was discussed by Michael Young and Jane Myles, with Viljena Trask highlighting the competitive nature of oncology site selection. Eliana R. Burke shared an encounter with a highly experienced clinical trial site, and Ira Snyder emphasized the need for balanced negotiations for successful collaboration.

A link to the slide set is here: {i need someone to do what’s needed here – embed a link to the slide set in pdf format}

Looking Ahead

The next GLSA event is scheduled for July 17, with the subject yet to be determined. To stay updated on GLSA | FOCM events, sign up here. Stay tuned for more updates and we look forward to seeing you at our next event!

 

ATTENDEES:

(First time attendees in bold)

Judy Woods

Jane Myles

Viljena Trask

Bill Dirkes

Tom Lo

Lauren Sherwood

Ira Snyder

Cameron Robinson

Eliana Rivera Burke

Jared Byer

Joan Chambers

Lori Leathers

Jon Carlson

Christine Martin

Hiro Matsushima

Duncan Shaw

Lauren Merante

Lisa Marie O’Brien

Michael Young

Marlyn Brookins

Dr. Syed Rooh ul Arifeen Naqvi

Irene Rivera

Julia Oxley

Yuko Terasawa

 

GLSA

Denise McNerney

Jim Sarene

Kelvin Izevbekhai

Rocio Rayna Reyes

Timmina Williams

Chris Matheus

May Networking Event Summary

Fifteen people attended our May event.

We opened with input from others about recent attendance at a variety of conferences. Whereas the first quarter of the year had conferences exceeding typical attendance and a buzz of activity, the 2nd quarter seemed flat, with typical attendance and the feeling of a lull in activity. As discussed in one of our events this past fall, so much uncertainty in the world causes people to be conservative and hold back in spending money and starting projects. Those factors are:
Israel – Hamas war
Ukraine – Russia war
US Inflation
US Interest rate
US Presidential election
Predictions of recession

The presentation title was: Proactive vs Reactive Cryotank Management and Will Baird, a co-founder at Boreas Monitoring was the presenter. Boreas was founded in Wilmington, NC. Chris Matheus had seen Will present at an entrepreneurship/venture funding event at the Marine Biotech Center at UNC Wilmington in 2023.

Boreas was founded by lab professionals with over 80 years of industry experience owning/operating fertility laboratories. The CryoScout system was developed while the founders managed cryotanks, identifying inherent flaws in the temperature-based monitoring systems commonly used throughout the industry. It was accelerated by two high profile tank failures in 2018 that resulted in millions of dollars in lawsuits and catastrophic loss of patient samples, destroying people’s hopes & dreams of having children. They developed and patented a weight-based monitoring system — the most reliable method of determining the evaporation rate of a cryotank. It can detect a failure up to 84 hours earlier than temperature-based methods, giving labs a data-driven solution to monitor their tanks, along with enough time to save samples from being destroyed.

As a reminder, treat these events as an “open house” – drop in when you can and leave when you need to.

The link to get notifications of our future online and live events is: https://bit.ly/3UTb8hL

As our passion is to connect people and companies we know, like and respect to other people and companies we know, like and respect we always have everyone put the link to their LinkedIn profile in the chat to allow for easy connecting and future follow up.

GLSA’s LinkedIn page can be reached here: http://www.linkedin.com/company/global-life-sciences-alliance/

A reminder that Global Life Sciences has a select network of 50 clinical research service providers and we want to be seen as a resource to you and to the industry. So when you run into an issue or have a need, give us a call. It’s what motivates us, we quickly reach out to our contacts to find the solution you’re looking for.

The next event will be on June 12, a week earlier than normal due to the DIA Annual Meeting. The focus will be on a review of the first half of the year – comparing to last year and seeing what the sense of the industry is: trends, changes, etc.

ATTENDEES:

Will Baird, Boreas Monitoring
Jeanne Schow, Bleu Sales Leadership
Michael Young, biomedwoRx
Steve Sisson, MLM Medical Lab
Allie Ash, Colorado State University
Brandon Cantwell, Clinical Project Manager
Cameron Robinson II, Mustard Seed PMO
Eliana Rivera Burke, GreenLight Clinical
Joan Chambers, Tufts
Karen Tkaczyk, Vistatec
Lakshmi Ethirajan, Smabio

GLSA
Denise McNerney
Chris Matheus
Alex Hoppe

March 2023 Networking

The March FOCM | GLSA Networking event started out with welcoming everyone and reminding attendees of the meetings guidelines:

  • Think of this as an open house event – drop in when you can and leave when you need to; 
  • When we have a presenter we have them start when we have assembled a strong amount of respondents – usually 10-15 minutes after the start. 
  • Presenters’ topics are not sales pitches – the focus is on an aspect of clinical trials; where in the process their services are used and aspects of that step. 
  • The link to get the GLSA newsletter and notifications about future live and virtual events:  http://bit.ly/3UTb8hL
  • We ask everyone to put their LinkedIn link into the chat to facilitate connecting and future follow up. 

In GLSA news: it was announced that co-founder, Denise McNerney had moved from Virginia to Florida. She is enjoying pointing out the weather to those north of where she now lives. I gotta say, she’s enjoying it a bit too much.  https://globallifesciencesalliance.com/

Cass Hui – founder of Heal Mary was then introduced to the attendees. She shared her story of how she came from the tech industry into the clinical research industry. Her mom first and then two sisters all had breast cancer. Cass encountered frustrations in finding clinical trials for them to consider and decided to apply her experience and skills to making this easier for others. Rather than becoming a patient recruitment company, she provides her service in the software as a service (Saas) model. Multiple patient advocacy and disease foundations are using her platform to inform people about clinical trials.  https://healmaryapp.com/search

Cass utilized the kahoot.it platform to poll/question the attendees about clinical trial recruitment information. This was a fun way to get people thinking about the topic and led to a lively question and answer session. 

After the Q&A, we broke into separate breakout rooms for people to introduce themselves, their companies and their needs to the others in the room.   

The April event will feature Joseph Cheng with PiVOT CRO  on the demographics, clinical research experience and capabilities of the Philippines.

Attendees:
Cassandra Hui; Heal Mary and evening presenter
Stacey Richardson; Parexel
Mike O’Gorman; Life Science Marketplace
Dave Gibboni, Beigene
Amy Lee; Kaiser Permanente
Loretta Cipkus Dupray; Global Clinical Connections
Peter Payne; Consultant
Matthew Plaud, Consultant
Nancy Zeleniak; Advocate Health
Joseph Cheng; PiVOT
Jean-Pascal Rugiero; SVM Pharma
Rodan Zadeh; Consultant
Kim New, ClinChoice
Duncan Shaw; DTS Language Services
Maria Frane; Corlexia
Gabrielle DeBoer; Consultant
Arti Bhosale, Sieve Health

GLSA Attendees:
Holly Cliffe
Sally Haller
Hannah Lloyd
Jordan Brown
Joe Buser
Timmina Williams
Megan Hoffman
Charity Dube
Chris Matheus
Denise McNerney
Ori Geshury
Liz Mirra
Alex Hoppe
Shiquita Hinton
Whitney Davis

A couple snapshots from the event are below:

Screen shot #1
Screen shot #2
Screen shot #3
Screen shot #4

 

January Networking Event

The January FOCM | GLSA Networking event started out with welcoming everyone and wishing everyone a Happy New Year! 

A review of the events guidelines was stated – think of this as an open house event – drop in when you can and leave when you need to; when we have a topic and presenter we have them start when we have assembled a good number of people and that’s usually 10-15 minutes after the start. Presenters’ topics are not sales pitches – the focus is on an aspect of clinical trials, where their services are used and what they offer. 

The link to get notifications about our future live and virtual events>>  http://bit.ly/3UTb8hL

As our passion is to connect people and companies we know and like to other people and companies we know and like, we asked everyone to put into the chat the link to their LinkedIn profile. This allows for quick and simple connecting and facilitates future follow up.

We opened the event sharing industry updates, news, and/or gossip that anyone wanted to bring up. Then the focus of this event was on cold chain logistics. Loretta then began the presentation portion with an overview of managing cold chain shipments. There are several categories of temperature control: ambient (room temperature), refrigerated, frozen and sub-zero. The regulations and guidelines for handling temperature excursions was reviewed. Examples of the financial and product losses that have occurred from situations where the temperature was not maintained were discussed. Then Rafa and Victor shared how CoolChain’s products and services are used to maintain temperature across all the categories. The boxes that they use can maintain a temperature for any of the ranges for up to 120 hours (5 days). A key benefit is that a refrigerated truck container isn’t needed and you can transport products in one shipment that are from each of the temperature categories. Another very important part is to minimize waste. Rather than use single use containers, CoolChain’s shipping containers are reclaimed and can be re-used for up to 2 years.

Attendees:

Rafa Martin-Alos Cool Chain
Victor Camacho Cool Chain
Loretta Cipkus Dubray Global Clinical Connections
Joseph Cheng PiVOT
Mike O’Gorman Life Science Marketplace
Brian Langin Diligent Pharma
Liz Mirra Mirraponte
Ori Geshury Mirraponte
Duncan Shaw DTS Language Services
Scott Robertson Mednet
Griffin Robertson Mednet
Jeff Page Consultant
Kate Mullis ICON GPHS

GLSA Attendees:

Denise McNerney
Chris Matheus
Joe Buser
Charity Dube
Hannah Lloyd
Sally Haller
Daryl Oberg
Holly Cliffe
Timmina Williams

A screenshot from the event is below:

January Event Screenshot

December Networking Event

The December FOCM | GLSA Networking event started out with welcoming everyone and a review of these meetings’ agendas summarized in the paragraph below. 

For the newcomers, think of this as an open house event – drop in when you can and leave when you need to; when we have a topic and presenter we have them start when we have assembled a good number of people and that’s usually 10-15 minutes after the start. 

There were several (ahem) great looking holiday sweaters and several pets were seen on camera as well. Candy Dupree won best outfit hands down.  The link to get notifications about our future live and virtual events>>  http://bit.ly/3UTb8hL

As our passion is to connect people and companies we know and like to other people and companies we know and like, we asked everyone to put into the chat the link to their LinkedIn profile. This allows for quick and simple connecting and facilitates future follow up.

We opened the event sharing industry updates, news, and/or gossip that anyone wanted to bring up. Chris shared that GLSA has contracted with two new clients: Validcare and Cool Chain to help the in their promotional and sales efforts. Validcare is disrupting clinical research with an all digital approach and fixed price study management. Cool Chain has shipping containers that can maintain a specified internal container temperature for 120 hours, be that sub zero frozen, frozen, refrigerated or room temperature. One of our clients Heal Mary, a SaaS AI enhanced patient recruiting platform has been awarded a project from a company we introduced them to and that will begin in February.

The group chose not to go into smaller breakout sessions, so we stayed in one room and talked about the holidays and what people’s plans were. We acknowledged the industry begins to get quite busy by the third week of January and we’re bracing for it. 

Attendees:

Mike Burrows Burrows Life Sciences Associates, PLC
Arti Bhosale Sieve Health
Duncan Shaw DTS Language Services
Nancy Zeleniak Atrium Health
Debbie McCoy Business Development Consultant
Michael Young biomedwoRx; Life Sciences Consulting
Eric Nier Block Clinical
Erica Hill Marketing Consultant
Judy Carmody Carmody Quality Solutions
Charles Speno TrialX
Holly Jochims Adaptive Clinical Systems
Kim Lupo Portrett Pharmaceuticals
Nadia Bracken Clinical Operations Director
Shruti Vashisht Software Development
Chris Clancy Medidata
Jon Matheus A.T. Pancrazi Real Estate
Ori Geshury Mirraponte
Liz Mirra Mirraponte
Loretta Dubray Global Clinical Connections
Mike O’Gorman Life Science Marketplace
Candy Dupree Adam’s Bridge Global

GLSA Attendees:

Denise McNerney
Chris Matheus
Joe Buser
Megan Hoffman
Charity Dube
Hannah LLoyd
Sally Haller
Timmina Williams
Holly Cliffe

A few screenshots from the event are below:

Screen shot #4
Screen Shot #3
Screen shot #2
Screen shot #1

November Networking Summary

Participants at the The GLSA | FOCM Networking event that took place on November 16, 2022 were treated to a presentation from Chuck Bon with Biostudy Solutions. Chuck is a recognized industry expert in the area of pharmacokinetics and biostatistics. Chuck has served on FDA Expert and Blue Ribbon panels on Topical Corticosteroids and Population and Individual Bioequivalence. Biostudy Solutions has expertise in trial design of Phase 1 PK Bioequivalence (BE) studies as well as Therapeutic Equivalence Trials.  The company specializes in the analysis of PK studies, bioequivalence studies and  results from alternative in-vitro testing. 

A discussion about the therapeutic equivalence of generic drugs to the original branded product took place. There is a tolerance range of bioavailability when comparing to the standard. The bioequivalence range for the Test-to-Reference ratio in both PK and clinical endpoint trials is 80% to 125%.  

There was discussion over the ongoing mergers and acquisitions among small CROs to lift themselves into the mid-size CRO ranks.

Let’s continue to reinforce our collective goal to improve patients’ lives across the globe. If you would like to present on an educational life sciences topic and spur our discussions, please leave a comment below and I’ll reach out as soon as possible.

If you are in need of more information of BioStudy Solutions, please click below:

https://biostudysolutions.globallifesciencesalliance.com/

Attendees (first time attendees in bold):

Dan Weddle, Senior Strategic Alliance Director, AltaSciences
Jill Curtis, Director of Project Management, Worldwide Clinical Trials
Duncan Shaw, President, DTS Translation Services
Ashley Clark, Regulatory Affairs Consultant
Ryan McCarthy, Government Markets Manager, Velocity BioGroup
David Holland, Senior Director of  Business Development, cMed Clinical
Jim Lyon; Professor of Clinical Research; UNC – Wilmington
Nancy Zeleniak, Enterprise Strategic Partnerships and Participant Engagement, Atrium Health
Judy Carmody, Founder, Carmody Quality Solutions
Michael Young, Founder & Principal, biomedwoRx
Josh Lang, Associate Director, Business Development, Asymchem Group
Loretta Cipkus Dubray, Founder, Global Clinical Connections
Ravi Luthra, Clinical Research Coordinator
Mike O’Gorman, Founder, Life Science Marketplace

GLSA:
Joe Buser
Hannah Lloyd
Denise McNerney
Sally Haller
Chris Matheus
Megan Hoffman
Charity Dube
Timmina Williams

A few screenshots are below:

Screen shot #1
Screen shot #2
Screen shot #3
Screen shot #4
Screen shot #5

October Networking Summary

The GLSA | FOCM Networking event that took place on October 19, 2022 was well attended with 17 participants.  

With Chris Matheus returning from a trip to Arizona, Denise awkwardly tried to lead the group. After a bit of a rough start, she improved vastly and we’re all quite proud of her ability to make lemons out of limes. 

A discussion about decentralized trials and the use of medical professionals to make patient visits proved interesting. Ellen Weiss with PCM Trials discussed how they have played a pivotal role in the use of Certified Mobile Research Nurses.

Michael Young added more good words. 

It was nice to have Michelle Ashton and her colleague Sarah Buchholz from IssueTrak join. Michelle worked with GLSA in its early days and we’re big fans of her work ethic and talents. 

Let’s continue to reinforce our collective goal to improve patients’ lives across the globe. If you would like to present on an educational life sciences topic and spur our discussions, please leave a comment below and I’ll reach out as soon as possible.

https://globallifesciencesalliance.com/solutions/

Attendees (first time attendees in bold):
Heather Hollick; Founder of Rizers LLC; Author of “Helpful, A guide to life, careers and the art of networking”
Arti Bhosale, CEO, Sieve Health
Michael Braddock II, Chief Revenue Officer, Frontier Scientific Solutions
Ellen Weiss, Vice President, PCM Trials
Ryan McCarthy, Government Markets Manager, Velocity BioGroup
Edwin Gershom, Business Development Manager, Noble Life Sciences
Candy Dupree, National Sales Director, AdamsBridge Global
Michelle Ashton, Business Development Manager, IssueTrak
Sarah Buchholz, Digital Marketing Strategist, IssueTrak
Michael Young, Founder & Principal, biomedwoRx
Brian Langin, Business Development Consultant
Ravi Luthra, Clinical Research Coordinator

GLSA:
Joe Buser
Holly Cliffe
Denise McNerney
Sally Haller
Megan Hoffman

A few screenshots are below:

Screen shot #1
Screen Shot #2
Screen Shot #3
Screen shot #4

September Networking Event Summary

The GLSA | FOCM Networking Event on Wednesday, September 21, 2022 at 5:00 PM EST was a fascinating presentation by Patrick McCarthy and Steve Galen of Validcare about a disruptive approach to the conduct of clinical trials. Recent advances in technology and learning to do things remotely due to COVID-19 helps make this possible. Not only is it possible, it is being done and Validcare is at the forefront.

https://validcare.globallifesciencesalliance.com/

The current clinical trial paradigm is broken. Decentralized clinical trials are proving not to be the solution. They’re merely a bolt-on expense that helps with patient access and engagement. DCTs do not reduce costs nor delays caused by inefficient data management, staffing and software systems. Validcare’s Digital 1st CRO Experience succeeds where DCTs do not. Finally we have the ability to fix the CRO Model and put an end to low-ball proposals to win the project followed by significant change orders shortly after study start-up.

Validcare’s platform puts the entire study in one cloud environment. This has been built by experienced industry insiders who knew that to fix the CRO model it had to be re-engineered from the outside. The platform has been designed on these principles:

  • Transparency
  • High performance
  • Low maintenance
  • Turn-key

As such it provides for predictable financial performance allowing for a fixed price for study conduct.

To nobody’s surprise, we couldn’t stay away from discussing the Fall conference schedule and who was intended to go to which events. It looks like a full return to in-person events with DPharm, SCDM, OCT New England, CNS Summit, MAGI West, CTS East Coast, etc.

Andrew Mulchinski stated that Symbio hasn’t fully adapted to DCT yet, sparking the post-quarantine observations of many regarding the transition to decentralized and hybrid studies.

Let’s continue to reinforce our collective goal to improve patients’ lives across the globe. If you would like to present on an educational life sciences topic and spur our event discussions, please leave a comment below and I’ll reach out as soon as possible.

Attendees (first time attendees in bold):

Julia Love, CEO, Love Contracts
Candy Dupree, National Sales Director, AdamsBridge Global
Himanshu Desai, Global Head PV QA, Novartis
Mike O’Gorman, CEO Life Science Marketplace
Mindy Bertram, Owner, CMB Consultants
Andrew Mulchinski, Business Development, Symbio Research
Wayne Whittingham, Vice President, Regulatory,  Cardio Pharma
Duncan Shaw, CEO, DTS Language Services
Katherine Cloninger, Senior Director, Brand Marketing, Parexel
Ravi Luthra, Clinical Research Coordinator

GLSA:
Chris Matheus
Joe Buser
Holly Cliffe
Denise McNerney
Sally Haller
Hannah Lloyd-Clark

A few screenshots are below:

Screen Shot #3

August Networking Summary

Buying and Selling with Great Technology!

The GLSA | FOCM Networking Event on Wednesday, August 17th, 2022 at 5:00 PM EST was expectedly light in attendance with many of our friends and colleagues taking a well-earned break during these summer months. 

Our guest speaker, Michael O’Gorman, CEO of Life Science Marketplace, treated us to a demonstration on how to use his innovative pricing tool for Sponsors and Vendors to connect and access more information, providing a more competitive bidding experience and allowing vendors to highlight their strengths and set themselves apart from the majority. 

Our own Chris Matheus and Denise McNerney were attending a live event that GLSA and FOCM Networking were co-hosting with ProTrials Research in Raleigh, NC at the AC Hotel Level 7 Rooftop Bar and thus did not join our virtual meeting. 

For those who missed the event and would like to learn how to buy and sell with Michael’s platform, please feel free to watch the video:

Insert video link here:

 

For more information or to schedule a more in-depth demonstration please contact “>Hannah Lloyd or fill out this form and we will be happy to assist you.

Let’s continue to reinforce our collective goal to improve patients’ lives across the globe. If you would like to present briefly on an educational life sciences topic and spur our event discussions, please leave a comment below and I’ll reach out as soon as possible. Our next event is scheduled for September 21 and CoolChain has been invited to discuss how how to ship and maintain temperature controlled shipments with eco-friendly reusable cold chain shipping containers. 

Attendees included people from these organizations:

biomedWorx,  Life Science Marketplace, Cmed Clinical Services, Curebase,  EmVenio as well as several GLSA staff.

Photos of the event:

Engaged attendees
Capture of the action

July Networking Summary

The GLSA | FOCM Networking Event on Wednesday, July 20th, 2022 at 5:00 PM EST was a lively affair boasting a diverse crowd of life science professionals. Many who attended were the previous colleagues and / or the current friends of Chris Matheus (FOCM, President; GLSA Chief Commercial and Networking Officer).

The topic of the day was “Summer Fun” due to the prevalence of the industry to go semi-dormant in July and August to accommodate the well-deserved vacations of its workers. The introduction, led by Chris, briefly spoke of former events which usually involved the related capabilities or education topic of a guest speaker to spur industry-related discussions and aid in collaboration among the group. He expressed the intention of this event to be focused more on the personal activities and vacations of attendees in order to keep our minds on the relaxation of these summer months. 

To nobody’s surprise, we couldn’t stay away from discussing work including the most recently held conferences; BIO International Convention in San Diego, CA and DIA Annual Meeting in Chicago, IL with a specific mention about the limited presence of sponsors. An outbreak of Coronavirus at these events and the apparently foul-tasting Paxlovid medicine used to treat moderate cases of COVID sparked conversation about who among us has contracted the virus and the varying degrees by which each individual was affected. 

Andrew Mulchinski stated that Symbio hasn’t fully adapted to DCT yet, sparking the post-quarantine observations of many regarding the transition to decentralized and hybrid studies. Chris noted a number of CRO’s that have changed leadership or have been acquired by other companies.

By far the most celebratory moment of the event was the announcement of the recent success of the Memorial Sloan Kettering Cancer Center in a small clinical trial using immunotherapy. They achieved 100% remission of rectal cancer without the use of surgery, chemotherapy or radiation that can leave patients with life-long effects including infertility and colostomy bags.

Let’s continue to reinforce our collective goal to improve patients’ lives across the globe. If you would like to present briefly on an educational life sciences topic and spur our event discussions, please contact me.

Attendees: (first time attendees in bold)

Kimberly Lupo, MS, MBA, RAC Founder & CEO at Portrett Pharmaceuticals LLC
Sara Tylosky CEO, Farmacon
Nadia M. Bracken Operational Advisor, Medidata
Brian Horan CEO & Co-founder, SupplyRx
Tina Tran Director, Business Development, Unlearn.ai
Heather Hollick Rizers LLC; Author of “Helpful, A guide to life, careers and the art of networking”
Amy Zastawney Seeking a new executive business development role
Jon Matheus Commercial Real Estate, A.T. Pancrazi Real Estate Services
Unnat Patel Founder & President, AnalysisMate
Peter Payne Life Sciences Executive – Available for Consulting
Griffin Robertson Partner Account Manager, Mednet
Nancy Zeleniak Enterprise Strategic Partnerships & Participant Engagement; Atrium Health
Dhruv Wadhwa Director of Business Development, HUMA
Michael Young Founder & Principal, BIOMedworx
Scott Robertson Vice President of Sales, Global Partnerships; Mednet
Ravipal Luthra, MS, BDS Clinical Research Coordinator, University of Miami, Miller Medical Center
Andrew Mulchinski, MPA, MT, ASCP, CCRC Business Development; Symbio, LLC
Lani Hashimoto Associate Director Patient Engagement Management; Novartis
Amanda Putnam Team Lead Manager; Data Recognition Corporation
Michael O’ Gorman CEO and Founder at Life Science Marketplace
Eliana Burke Global Head of Client Engagement & Marketing; Greenlight Clinical
Michael Minor EVP, Clinical Research; IMA Clinical Research
Vaibhav Sawant Pharma Marketing Executive
GLSA ATTENDEES
Denise McNerney Chief Operations Officer
Hannah Lloyd Account Manager
Zulma Varela Director of Public Communications
Sally Haller Operations Manager
Todd Neilson Account Manager
Joe Buser Chief Revenue Officer
Chris Matheus Chief Commercial and Networking Officer
Yutong Liang Intern, Data Management and Technology

Screen shots of the event follow:

Screen shot at 6:02
5:45 P.M. Screenshot
Breakout rooms
5:21 screen shot
5:18 p.m. screenshot
5:06 screen shot
Start of meeting screen shot